Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
about
Deconstructing innate immune signaling in myelodysplastic syndromesCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Stochastic dynamics and the evolution of mutations in stem cellsA new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patientsSingle-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients.Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryAltered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemiaAlternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaIdentification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancersIdentification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells.Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.Treatment of chronic myeloid leukemia when imatinib fails.In search of CML stem cells' deadly weakness.Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy.Antigens in chronic myeloid leukemia: implications for vaccine development.Immunology and immunotherapy of chronic myeloid leukemia.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.Novel drug therapies in myeloid leukemia.Interleukin 33 is a guardian of barriers and a local alarmin.Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance.Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.Stem cell persistence in chronic myeloid leukemia.Where are we going with CML research?Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationGenome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations.On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population.Chronic myeloid leukemia: the basis of treatment for tomorrow.Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
P2860
Q26991974-ECF80DAB-56A3-4340-8DF5-725A019EF603Q28081844-63F0AF2C-D21C-40C2-B494-D26A0ACEF695Q31017219-B044B042-08C2-4ECA-AE2A-226DB217B6E9Q33820371-2F04D0E1-4DBD-4779-85E0-5CD5E4F331C9Q33834587-90212824-48F0-41F9-AA12-105A6B98B211Q34154786-E1AFB346-5242-4E25-BEA6-64F1992825D5Q35016953-449F5105-2B37-4A05-BB3E-3740C651747CQ35044993-6341597D-FC5D-4D45-81A5-D541668572DDQ35634865-4EB973FB-5448-4127-AAA8-070CC4A4AB5DQ35903505-A38D5247-910C-4183-A015-2D3D0116A234Q35931271-66DB47F0-C04C-4808-BAF2-5524AE824301Q36008395-847FDB4D-A662-4B05-A707-44BD82969C2AQ36163066-EDB1F75B-B91B-4DCD-B831-0641C9BAF9D2Q36210636-983CB473-CEFB-4F8C-BDE8-1063CC4944C1Q36470331-E1DEA18F-58BA-4256-BC52-0F3EB839B187Q36755221-B176DC1D-A663-42A1-B52D-C17BAF6BFB32Q36957067-0D98618A-6B51-472F-A954-D0203ACEE8FEQ37487526-1D4551C1-665F-4C35-8920-0FB0C2E98637Q37702727-F3EEAFA7-44FE-46C4-838C-C4022FFDB1E6Q37827875-A529E7CC-CB05-43AA-B472-D863133809E1Q37849628-F3171A1D-6B04-4561-8EA4-FB2D43BA0702Q37906461-E5471C61-7869-42EC-B70F-5B46AF857DD0Q37950233-1F2B9CD8-D2D3-4434-9163-E6F7CC6889A9Q38175864-21B33B19-7F1F-476A-908C-1E40916C071BQ38203882-41EA001C-6064-4E7F-9E44-6E6C85AFDA0DQ38265115-229E9F3C-5796-4D97-B37C-3FFEA066D7A1Q38510486-199D58C3-CDCD-4CB2-8ED4-3270CCFD4EBFQ38702558-38C65834-F2FB-46CC-B512-D7FEF88C3D3AQ38797633-186B3D2F-5930-40C3-944D-45DCB7AF88F5Q38812117-77D0EAA1-7528-4C38-AF84-D50F2294AC23Q38866390-A9816B34-361A-4488-B3E2-0251F6A5ECC2Q39411920-261FC8F5-DEB1-4CF0-A0ED-0767298FF10DQ39795335-FF626152-BF2D-4C67-A238-2FD81B9C1911Q40817591-BFC20ACB-D2C4-4EBD-9ED4-5BE5F574F06BQ40817656-6DED7E08-A16F-4DF7-BD10-E0B756898200Q41610510-DFBEFD54-341F-4E1F-8083-3E7970CA0335Q41808859-230121DD-A0A7-40A4-A890-0F6D9634BD35Q42111604-C87983A5-AF36-4D6F-89B1-C759D9852297Q43004416-E2C5CFF0-B2A3-4314-8BA7-998B4A418D0CQ45340032-BD7FC901-9213-435E-9754-0AA8F8C6D6D7
P2860
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Isolation and killing of candi ...... -1 receptor accessory protein.
@ast
Isolation and killing of candi ...... -1 receptor accessory protein.
@en
Isolation and killing of candi ...... -1 receptor accessory protein.
@nl
type
label
Isolation and killing of candi ...... -1 receptor accessory protein.
@ast
Isolation and killing of candi ...... -1 receptor accessory protein.
@en
Isolation and killing of candi ...... -1 receptor accessory protein.
@nl
prefLabel
Isolation and killing of candi ...... -1 receptor accessory protein.
@ast
Isolation and killing of candi ...... -1 receptor accessory protein.
@en
Isolation and killing of candi ...... -1 receptor accessory protein.
@nl
P2093
P2860
P921
P356
P1476
Isolation and killing of candi ...... -1 receptor accessory protein.
@en
P2093
Carin Lassen
Helena Agerstam
Johan Richter
Marcus Järås
Marianne Rissler
Nils Hansen
Panagiotis Tsapogas
Petra Johnels
Thoas Fioretos
Tor Olofsson
P2860
P304
16280-16285
P356
10.1073/PNAS.1004408107
P407
P577
2010-08-30T00:00:00Z